Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.

Robert J OlsonMitchell LiuAlanah BergmanSonya LamFred HsuBenjamin MouTanya BerrangAnte MestrovicNick ChngDerek HydeQuinn MatthewsChad LundDaniel GlickHoward PaiParminder BasranHannah CarolanBoris ValevShilo LefreseneScott TyldesleyDevin Schellenberg

Published in: BMC cancer (2018)

Registered through clinicaltrials.gov NCT02933242 on October 14, 2016 prospectively before patient accrual.

Keyphrases

early stage
case report
locally advanced
radiation therapy
radiation induced
brain metastases
small cell lung cancer
randomized controlled trial
rectal cancer